Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Journal of Medicinal Chemistry
|
October 3, 2012
Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors
Tao Liu, Somarajan J Nair, André Lescarbeau, et al.
Blood
|
December 14, 2017
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma
Steven M Horwitz, Raphael Koch, Pierluigi Porcu, et al.
Antiviral Research
|
January 14, 2025
Corrigendum to "Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B" [Antivi. Res. 231 (2024) 1-13/106017]
Yijie Tang, Mingzhu Xu, Cong Wang, et al.
Nature
|
November 10, 2016
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau, Matthew Rausch, David Winkler, et al.
Journal of Translational Medicine
|
January 10, 2024
Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis
Xin Tracy Liu, Yu Huang, Da Liu, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 11, 2018
Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK Workshop
Anna Zuk, Paul M Palevsky, Linda Fried, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 5, 2020
Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics
Timothy Papaluca, Stuart K Roberts, Simone I Strasser, et al.
Journal of Hepatology
|
November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program
Christiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
Ebiomedicine
|
April 1, 2023
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Journal of Medicinal Chemistry
|
October 3, 2012
Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors
Tao Liu, Somarajan J Nair, André Lescarbeau, et al.
Blood
|
December 14, 2017
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma
Steven M Horwitz, Raphael Koch, Pierluigi Porcu, et al.
Antiviral Research
|
January 14, 2025
Corrigendum to "Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B" [Antivi. Res. 231 (2024) 1-13/106017]
Yijie Tang, Mingzhu Xu, Cong Wang, et al.
Nature
|
November 10, 2016
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau, Matthew Rausch, David Winkler, et al.
Journal of Translational Medicine
|
January 10, 2024
Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis
Xin Tracy Liu, Yu Huang, Da Liu, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 11, 2018
Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK Workshop
Anna Zuk, Paul M Palevsky, Linda Fried, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 5, 2020
Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics
Timothy Papaluca, Stuart K Roberts, Simone I Strasser, et al.
Journal of Hepatology
|
November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program
Christiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
Ebiomedicine
|
April 1, 2023
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, et al.
Page
of 5